Special Issues
February 2014
Volume: 3
Issue: 1
February 2014
Volume: 3
Issue: 1
December 2013
Volume: 2
Issue: 6
Winter 2013
Volume: 5
Issue: 4
November 2013
Volume: 2
Issue: 4
Fall 2013
Volume: 5
Issue: 3
September 2013
Volume: 2
Issue: 4
September 2013
Volume: 2
Issue: 3
Summer 2013
Volume: 5
Issue: 2
June 2013
Volume: 2
Issue: 3
June 2013
Volume: 2
Issue: 2
Spring 2013
Volume: 5
Issue: 1
April 2013
Volume: 2
Issue: 2
April 2013
Volume: 2
Issue: 1
February 2013
Volume: 2
Issue: 1
December 2012
Volume: 1
Issue: 4
November 2012
Volume: 1
Issue: 2
September 2012
Volume: 1
Issue: 3
Summer 2012
Volume: 4
Issue: 2
June 2012
Volume: 1
Issue: 2
May 2012
Volume: 1
Issue: 1
May 2012
Volume: 1
Issue: 1
Spring 2012
Volume: 4
Issue: 1
Fall 2011
Volume: 3
Issue: 3
Summer 2011
Volume: 3
Issue: 2
Spring 2011
Volume: 3
Issue: 1
Winter 2010
Volume: 2
Issue: 4
Fall 2010
Volume: 2
Issue: 3
Summer 2010
Volume: 2
Issue: 2
Spring 2010
Volume: 2
Issue: 1
Advertisement
Advertisement
Trending on OncLive
1
Dr Mesa on the FDA Approval of Ropeginterferon Alfa-2b for Essential Thrombocythemia
2
Zanidatamab Plus Chemotherapy Improves OS at Second Interim Analysis of HERIZON-GEA-01 in First-Line HER2+ GEA
3
Savolitinib Plus Osimertinib Improves First-Line PFS in MET-Overexpressing EGFR-Mutated NSCLC
4
TTFields Add a New Dimension to the Changing Pancreatic Cancer Treatment Paradigm
5